Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study
de Sousa L, Liu S, Bhosale P, Altan M, Darbonne W, Schulze K, Dervin S, Yun C, Mahvash A, Verma A, Futreal A, Gite S, Cuentas E, Cho W, Wistuba I, Yao J, Woodman S, Halperin D, Ferrarotto R. Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study. Oral Oncology 2024, 151: 106747. PMID: 38460288, DOI: 10.1016/j.oraloncology.2024.106747.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply